Wild Bioscience has acquired F1 Seed Tech for an undisclosed amount, marking a significant expansion in the plant biotechnology sector. F1 Seed Tech is a pioneering breeder specializing in cannabis F1 hybrids, with operations spanning the US, Holland, Spain, and Israel. The acquisition integrates F1 Seed Tech's advanced breeding capabilities into Wild Bioscience's portfolio.
F1 Seed Tech focuses on developing F1 hybrid seeds that offer improved uniformity, yield, vigour, and disease resistance, aiming to transform cannabis into a mainstream agricultural crop. Their team, comprising academic research and business professionals with over fifty years of collective experience in life science, plant breeding, and biotechnology, has developed F1 hybrid seeds capable of exceeding the yield and cannabinoid content of traditional seeds by over 50%. These innovations provide sustainable, scalable, and reliable cannabis starting material, making crop management more efficient through higher yield potential and lower agronomic costs for both high-THC and high-CBD varieties.
This strategic acquisition is expected to leverage F1 Seed Tech's state-of-the-art breeding technologies and established global presence, including day-neutral breeding stations in Oregon, short-day stations in Kibbutz Ruhama, and facilities in Barcelona and Eindhoven. By integrating F1 Seed Tech's expertise in uniform heterozygous F1 hybrid seeds, which are suitable for direct cultivation without requiring clonal technologies, Wild Bioscience strengthens its position in agricultural innovation and plant science. The synergy will enable the combined entity to accelerate the development and distribution of advanced plant genetics.
The acquisition underscores a commitment to advancing agricultural practices through scientific innovation. The combined entity is poised to further drive the transformation of cannabis cultivation, meeting the evolving needs of growers and retailers globally with superior genetic material and efficient crop solutions.